Entrada Therapeutics, Inc. (TRDA)
NASDAQ·Healthcare·Biotechnology
$6.70
+4.52%
Mkt Cap $274.07M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$13.50
Range $10.00 – $17.00
Implied Upside
+101.6%
Consensus $13.50 vs current $6.70
NASDAQ·Healthcare·Biotechnology
$6.70
+4.52%
Mkt Cap $274.07M
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$13.50
Range $10.00 – $17.00
+101.6%
Consensus $13.50 vs current $6.70